All safety profile Articles
-
534ClinicalLow-Dose Atropine: Where Are We Now?
Get an in-depth look at the current state of low-dose atropine for myopia management. March 16, 2026 By Huy Tran and Nguyen...
-
785Research ReviewIncidence of Microbial Keratitis Associated with Overnight Orthokeratology
December 2, 2024 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE Orthokeratology has gained popularity as a method for temporarily...
-
1.5KKey IssuesNoteworthy Research From the 19th International Myopia Conference
October 10, 2024 Researchers in the field of myopia management from across the globe gathered in Hainan Island, China, for the International...
-
1.2KIn The PipelineDopavision’s Latest MyopiaX-1 Clinical Trial Data Shared at IMC 2024
October 7, 2024 BERLIN, Germany — Dopavision presented its six-month clinical trial data from its MyopiaX-1 trial at the 2024 International Myopia...
-
3.1KClinicalThe Ins and Outs of Vyluma’s CHAMP Study
sponsored content June 1, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management At this year’s Global Specialty Lens Symposium, Mark...